The phrase "administration of aggressive" is not correct and lacks clarity in written English.
It may be intended to refer to the management or delivery of aggressive treatments or strategies, but it needs additional context to be usable.
Example: "The administration of aggressive therapies is essential for treating advanced cancer patients."
Alternatives: "management of aggressive" or "delivery of aggressive".
The administration of aggressive diuretic therapies has generated concerns about renal safety, and some controversial results have been published in recent years [ 27, 28].
Another often accepted but poorly defined risk is the contribution of electrolyte disturbance during acute administration of aggressive loop diuretic therapy with AHFS admissions.
Despite the administration of aggressive treatments, the prognosis is poor, with the median overall survival (OS) ranging from 8 to 16 weeks [ 1, 2].
Determination of the monoclonality of the deposited immunoglobulin is vital to make the correct diagnosis and enable an early administration of aggressive immunosuppressive therapy.
Identifying clonal expansion in this way could potentially help predict transplant rejection before it occurs, giving physicians evidence to support the administration of more aggressive immunotherapy.
In clinical practice, the administration of more aggressive therapy to higher risk patients may mask therapeutic benefit.
Several studies have reviewed small series of patients and suggested an early administration of highly aggressive treatment for nasal-type NK/T cell lymphoma.
The second major manifestation of overtreatment is the administration of more aggressive therapies than is necessary to 'true' but very early stage cancers [ 16, 17].
On the basis of our results, it can be proposed that pretreatment CTC counts may identify in advance patients who have higher risk of developing widespread visceral disease and consequently might benefit from early administration of more aggressive systemic treatments.
The strengths of the TODAY clinical trial were enrollment of participants soon after diagnosis of type 2 diabetes, administration of early aggressive therapy for type 2 diabetes, hypertension, and microalbuminuria, and the careful, comprehensive, prospective monitoring of subjects over 2 6.5 years of follow-up.
The president will have advisers who will be whispering cautions about the risks of committing the prestige of any administration to aggressive energy goals.
